Best hospitals in the US for rare diseases: An evidence-based guide to specialized care

For readers researching the best hospitals in the US for rare diseases, no single national ranking can identify the right institution for every condition. Rare diseases affect more than 30 million Americans, and more than 10,000 conditions have been identified, creating a need for highly specialized, multidisciplinary evaluation rather than a one-size-fits-all hospital choice. 2 The strongest candidates generally combine diagnostic expertise, specialty clinics, genetic services, research activity, and coordinated support for patients and families.

How to interpret “best” in rare-disease care

Hospital quality for rare disease is better assessed by clinical fit than by general reputation. Relevant factors include experience with the specific disorder, access to medical genetics and metabolic services, coordination across specialties, diagnostic testing, clinical research, and the ability to manage both pediatric and adult needs. NORD’s Centers of Excellence review criteria explicitly include comprehensive genetics and metabolic services, coordinated care, research, workforce training, and community education. 2

General hospital rankings can still provide context, but they do not establish expertise in every rare condition. Mayo Clinic in Rochester is frequently ranked among the leading US hospitals overall, while the NIH Undiagnosed Diseases Program is designed for patients who remain undiagnosed after extensive clinical evaluation. 10 11 A referral should therefore be based on the unresolved clinical question and relevant specialty, not only on a hospital’s overall position.

Major adult and multispecialty referral centers

Mayo Clinic is often identified as a leading institution for complex and rare-disease diagnosis. Cleveland Clinic is recognized for multidisciplinary care involving rare autoimmune and neurological disorders, and Johns Hopkins Medicine integrates genetic research with clinical care for complex rare conditions. 10 12 13 These institutions illustrate the value of combining multiple specialties when symptoms involve several organ systems or do not fit a conventional diagnosis.

In California, UCSF Health offers advanced genomic testing and clinical trials for undiagnosed or rare genetic disorders, while Mass General Brigham links major research capabilities with complex clinical care in the Boston area. 16 17 Cedars-Sinai was designated a NORD Rare Disease Center of Excellence in 2025 and joined a network focused on shortening diagnostic timelines, expanding access, and training specialists. 3 These examples show that research infrastructure can be as important as routine specialty services.

Leading pediatric hospitals and children’s programs

Boston Children’s Hospital is described in the research materials as a leading pediatric institution for rare genetic and developmental disorders and as the primary teaching hospital for Harvard Medical School. 14 The Children’s Hospital of Philadelphia also conducts substantial research in rare pediatric genetic conditions. 18 Pediatric programs are particularly important because approximately 70% of rare diseases begin in childhood, according to information associated with Atrium Health Levine Children’s Hospital. 8

Specialized children’s hospitals may provide developmental, neurological, orthopedic, genetic, and complex-care expertise in one coordinated setting. Gillette Children’s reports more than 125 years of experience caring for children with complex medical needs and emphasizes that concentration of cases can build familiarity with conditions encountered infrequently elsewhere. 9 For families, the practical question is whether the hospital can address the child’s full medical, developmental, educational, and quality-of-life needs over time.

What the NORD network indicates

The NORD Rare Disease Centers of Excellence Network offers one nationally organized framework for identifying institutions committed to rare-disease care and research. A July 2026 NORD announcement reported 49 designated members across 28 states and the District of Columbia, with affiliations spanning more than 170 academic medical centers, research institutions, and children’s hospitals. 1 The network is intended to connect expertise and share knowledge rather than create a universal ranking.

Recent designees demonstrate the range of participating models. UC Davis Health uses a comprehensive pathway extending from diagnosis to novel treatment development, including whole-genome sequencing and precision genomic research. 5 The University of Kansas Health System, Children’s Mercy, and the University of Kansas Medical Center were designated together, reflecting collaboration between pediatric, academic, and health-system services. 7 Northwell’s Cohen Children’s Medical Center was recognized for genetics, metabolic services, coordinated pediatric care, research, training, and education. 2

Matching a hospital to the condition

Rare-disease care is often organized around a specific disease, organ system, or diagnostic problem. Robert Wood Johnson University Hospital and Rutgers Robert Wood Johnson Medical School received NORD designation based substantially on their Cardiac Amyloidosis Center, which coordinates cardiology, neurology, hematology, nephrology, pathology, and bone marrow transplantation. 4 This model demonstrates why a hospital with deep experience in one rare disorder may be more appropriate than a larger institution with broader but less targeted expertise.

Patients with suspected genetic disorders may need clinical genetics, metabolic medicine, genomic testing, or an undiagnosed-disease program. Patients with rare cancers, immune disorders, neurological conditions, or connective-tissue diseases may need different specialty teams and research networks. The Rare Diseases Clinical Research Network supports collaboration among researchers and patient advocacy groups to study rare conditions and accelerate treatment development. 15 A medical record review should identify which services are essential before a referral is considered.

Practical limits, risks, and oversight

Travel to a nationally recognized center can create logistical and clinical burdens, including repeated visits, coordination with local physicians, and difficulty maintaining continuity between specialized and routine care. NORD’s network is designed to expand access and shorten diagnostic journeys, but designation does not mean that every center treats every rare disease or that a diagnosis or treatment is guaranteed. 1 Patients should verify the relevant clinic, specialist expertise, referral requirements, and whether research participation is separate from clinical treatment.

Clinical trials and experimental treatment development also require careful review. Research participation may involve eligibility criteria, protocol-specific testing, travel, uncertain results, and oversight distinct from ordinary care. The NIH Undiagnosed Diseases Program evaluates people whose conditions remain unresolved despite extensive evaluation, while RDCRN programs connect research teams and patient groups around defined disorders. 11 15 Insurance authorization, record transfer, genetic counseling, privacy, and long-term follow-up should be discussed with qualified clinicians before choosing a referral center.

Sources

1. National Organization for Rare Disorders, “National Organization for Rare Disorders Expands Rare Disease Centers of Excellence Network”
2. Northwell Health, “Cohen Children’s named Rare Disease Center of Excellence”
3. Cedars-Sinai, “Cedars-Sinai Joins Rare Disease Center of Excellence Network”
4. RWJBarnabas Health, “Robert Wood Johnson University Hospital and Rutgers Robert Wood Johnson Medical School Receive National Rare Disease Center of Excellence”
5. UC Davis Health, “UC Davis Health designated as a NORD Rare Disease Center of Excellence”
6. National Organization for Rare Disorders, “National Organization for Rare Disorders Adds Seven Rare Disease Centers of Excellence Nationwide”
7. The University of Kansas Health System, “NORD Rare Disease Center of Excellence Designation”
8. Atrium Health Levine Children’s Hospital, “Levine children’s hospital honored for rare disease care”
9. Gillette Children’s, “For Some Families, Rare Diseases Aren’t Rare”
10. U.S. News & World Report, Best Hospitals rankings
11. National Institutes of Health, Undiagnosed Diseases Program
12. Cleveland Clinic, Center for Rare Diseases
13. Johns Hopkins Medicine, rare-disease and genetic research information
14. Boston Children’s Hospital, rare-disease research information
15. Rare Diseases Clinical Research Network
16. UCSF Health, genomic testing and rare-disease clinical trials information
17. Mass General Brigham, complex medical care and research information
18. Children’s Hospital of Philadelphia, rare pediatric genetic research information